Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Non-cash Items (2016 - 2025)

Regenxbio (RGNX) has 12 years of Non-cash Items data on record, last reported at $8.0 million in Q4 2025.

  • For Q4 2025, Non-cash Items rose 3213.75% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, up 3213.75%, while the annual FY2025 figure was $8.0 million, 3213.75% up from the prior year.
  • Non-cash Items reached $8.0 million in Q4 2025 per RGNX's latest filing, up from $7.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $74.1 million in Q3 2021 and bottomed at $240000.0 in Q4 2024.
  • Average Non-cash Items over 5 years is $16.4 million, with a median of $7.3 million recorded in 2025.
  • Peak YoY movement for Non-cash Items: tumbled 96.58% in 2024, then surged 3213.75% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $41.1 million in 2021, then tumbled by 61.62% to $15.8 million in 2022, then plummeted by 55.58% to $7.0 million in 2023, then crashed by 96.58% to $240000.0 in 2024, then soared by 3213.75% to $8.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $8.0 million in Q4 2025, $7.7 million in Q3 2025, and $7.3 million in Q2 2025.